Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM8 | O00222 | 1/20 | 0.68 |
| ▸ | GRM6 | O15303 | 1/20 | 0.68 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.68 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.68 |
| ▸ | GSR | P00390 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.68 |
| ▸ | GRM5 | P41594 | 1/20 | 0.68 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.68 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.68 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.68 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.68 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.68 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.68 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.68 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.68 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.68 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.68 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.68 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30022755 | 1.00 | GRM8 (0.68) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL29438088 | 1.00 | GRM8 (0.68) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL30571083 | 1.00 | GRM8 (0.68) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL965272 | 1.00 | GRM8 (0.68) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL93830 | 1.00 | GRM8 (0.68) | GRM8GRM6GRIN2DGRIN3BGSR | |
| Bromide SCHEMBL31300189 | 0.97 | GRM8 (0.65) | GRM8GRM6GRIN2DGRIN3BGSR | |
| Hydrochloric Acid SCHEMBL18173930 | 0.97 | GRM8 (0.65) | GRM8GRM6GRIN2DGRIN3BGSR | |
| SCHEMBL10361106 | 0.97 | GRM8 (0.65) | GRM8GRM6GRIN2DGRIN3BGSR | |
| Hydrochloric Acid SCHEMBL2251424 | 0.97 | GRM8 (0.65) | GRM8GRM6GRIN2DGRIN3BGSR | |
| Water SCHEMBL2288176 | 0.97 | GRM8 (0.65) | GRM8GRM6GRIN2DGRIN3BGSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3373 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108454-A1 | Innate Targeting of Adoptive Cellular Therapies | QU BIOLOGICS INC (CA) | 2026-04-23 | — | — | US | claimed |
| EP-4702144-A1 | ANTISENSE OLIGOMERS FOR TREATMENT OF CHRONIC KIDNEY DISEASE | Sarepta Therapeutics, Inc. (US) | 2026-03-04 | — | — | EP | claimed |
| WO-2025223955-A1 | METHOD FOR PRODUCING POLYASPARTIC ACID, POLYASPARTIC ACID AND ITS USE | BASF SE (DE) | 2025-10-30 | — | — | WO | claimed |
| EP-4590347-A1 | NOVEL MINIGASTRIN-DERIVED CHOLECYSTOKININ 2 RECEPTOR BINDING MOLECULES FOR IMAGING AND TARGETED RADIOTHERAPY | Technische Universität München (DE) | 2025-07-30 | — | — | EP | claimed |
| CN-120189523-A | Method for the preparation of lipidated protein structures | 默克专利股份公司 | 2025-06-24 | — | — | CN | claimed |
| CN-119907695-A | Novel small gastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy | 慕尼黑工业大学 | 2025-04-29 | — | — | CN | claimed |
| WO-2025085810-A2 | ANTISENSE OLIGOMERS FOR TREATMENT OF CENTRONUCLEAR MYOPATHIES | SAREPTA THERAPEUTICS, INC. (US) | 2025-04-24 | — | — | WO | claimed |
| US-20250066776-A1 | ANTISENSE OLIGOMERS FOR TREATMENT OF CHRONIC KIDNEY DISEASE | SAREPTA THERAPEUTICS, INC. (US) | 2025-02-27 | — | — | US | claimed |
| WO-2024227040-A1 | ANTISENSE OLIGOMERS FOR TREATMENT OF CHRONIC KIDNEY DISEASE | SAREPTA THERAPEUTICS, INC. (US) | 2024-10-31 | — | — | WO | claimed |
| CN-118813314-A | Hard water resistant lubricant and preparation method and application thereof | 河北中煤神海科技发展有限公司 | 2024-10-22 | — | — | CN | claimed |
| EP-0205098-A2 | Influenza vaccine | National Institute of Health (JP) | 1986-12-17 | — | — | EP | claimed |
| EP-0100734-B1 | PROCESS FOR THE SEPARATION OR PURIFICATION OF A SLEEP PROMOTING FACTOR FROM A BIOLOGICAL SOURCE BY IMMUNOLOGICAL REACTION OF THE ANTIGEN-ANTIBODY KIND | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1986-12-17 | — | — | EP | claimed |
| US-4515891-A | ENZYMATIC HYDROLYSIS OF CELL WALLS OF LACTOBACILLUS OR CORYNEBACTERIUM | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1985-05-07 | — | — | US | claimed |
| EP-0015468-B1 | 6-DEOXYGLUCOSAMINE-PEPTIDE DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1982-12-29 | — | — | EP | claimed |
| EP-0002677-B1 | GLUCOSAMINE-PEPTIDE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS | Takeda Chemical Industries, Ltd. (JP) | 1982-10-13 | — | — | EP | claimed |
| US-4313871-A | Antigen for early pregnancy test and contraceptive vaccine | RESEARCH CORPORATION (US) | 1982-02-02 | — | — | US | claimed |
| US-4310455-A | Antigen for early pregnancy test and contraceptive vaccine | RESEARCH CORPORATION (US) | 1982-01-12 | — | — | US | claimed |
| US-4268435-A | Chorionic gonadotropin derived antigen for early pregnancy test and contraceptive vaccine | RESEARCH CORPORATION (US) | 1981-05-19 | — | — | US | claimed |
| US-4256629-A | SPECIFICITY FOR HUMAN CHORIONIC GONADOTROPIN | RESEARCH CORPORATION (US) | 1981-03-17 | — | — | US | claimed |
| US-4234561-A | RADIOIMMUNOASSAY, GONADOTROPIN | RESEARCH CORPORATION (US) | 1980-11-18 | — | — | US | claimed |